FDA chief nominee Scott Gottlieb’s changes may pressure generic drug prices, but there are other positives for the sector.

Sections:  business   
Topics:  health   
RELATED ARTICLES
    BING NEWS:
    • Bausch Health sues Amneal Pharma over Xifaxan generic
      In 2020, Bausch Health (BHC) reached agreements with generic drugmakers, including Teva Pharmaceuticals (TEVA) and Novartis' (NVS) (OTCPK:NVSEF) spinoff Sandoz (OTCQX:SDZNY) (OTCQX:SDZXF ...
      04/6/2024 - 2:32 am | View Link
    • More

     

    Welcome to Wopular!

    Welcome to Wopular

    Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

    Senh Duong (Founder)
    Wopular, MWB, RottenTomatoes

    Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

    MoviesWithButter : Our Sister Site

    More News